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Previous studies have demonstrated that insulin and
IGF-1 both increase lumbar sympathetic nerve ac-
tivity (LSNA) and decrease mean arterial pressure
(MAP). We hypothesized that the peripheral re-
sponses to insulin and IGF-1 are mediated, at least
in part, via the central nervous system. In this study
we determined the effects of the peripheral admin-
istration of both insulin and IGF-1 on cardiovascular
dynamics and LSNA following removal of the area
postrema (APX), a major site of blood-brain com-
munication. Insulin infusion in normal rats de-
creased MAP but increased HR and LSNA. When
insulin was infused in APX rats it also decreased the
MAP but the MAP recovered rapidly and plateaued
at a level equivalent to normals after 40min. Insu-
lin significantly increased the HR and LSNA in the
APX rats compared to normals. However, when hy-
poglycemia was prevented by glucose infusion,
the HR and LSNA responses to insulin in the APX
rats were similar to normals. IGF-1 also decreased
MAP and to a greater extent in the APX rats
compared to normals but the increased LSNA in
APX rats was equivalent to normals. The APX rats
when compared to normals had a greater sensitivity
to insulin-induced hypoglycemia while IGF-1 de-
creased the plasma glucose to a lesser degree in APX
rats. We conclude that insulin and IGF-1 entry into
the CNS at least via the area postrema does not
contribute significantly to the hypotensive response
and that the greater depressor response to IGF-1 is
likely due to enhanced vascular sensitivity in APX
rats. The increased HR and LSNA following insulin
were likely mediated by an increased reflexive
response to hypoglycemia.
Keywords: Area postrema, insulin, IGF-1, sympathetic ner-
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INTRODUCTION
Insulin and IGF-1 have homology in its molec-
ular structure and receptor structure as well as
metabolic effects. Our laboratory and others
have demonstrated that both insulin and IGF-1
act to modulate cardiovascular and sympathetic
nervous dynamics where they act to primarily
decrease MAP, increase blood flow in selected
vascular beds and increase sympathetic nerve
activity in rats (Pete et al., 1996; Pete and
Dunbar, 1998; Duanmu et al., 1997; Anderson
et al., 1991). We have also demonstrated that
insulin and IGF-1 injections into the lateral
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ventricles can also modulate cardiovascular and
sympathetic nervous dynamics (Hu et al., 1996).
Based on the above observation we hypothe-
sized that the action of peripheral insulin and
IGF-1 on these systems may, in part, be medi-
ated by CNS mechanisms.
The area postrema is a significant site of
communication in the blood-brain barrier be-
tween the humoral components of the blood and
the neural brain tissue (Ferguson and Bains, 1996;
Bernstein, 1996). It has been demonstrated that
the area postrema is especially significant in
mediating responses to nutrients in circulation
(Bernstein, 1996; Kenney et al., 1994; Calingasan
and Ritter, 1992; Adachi et al., 1991), as well as
other factors that mediate autonomic responses
(Nakayama et al., 1997; Wade et al., 1996). The
area postrema has been demonstrated to be
significant in mediating several cardiovascular
reflexes such as the response to exercise and
baroreflex mechanisms associated with angio-
tensin II (Bonigut et al., 1997; Cox and Bishop,
1991). Further supporting a role for the area
postrema in these processes is the fact that it
is juxtaposed and communicates with the nu-
cleus of the solitarius tract (NTS), a major site
of cardiovascular regulation (Cai et al., 1996).
Additionally, both insulin and IGF have been
demonstrated to have abundant receptors at the
level of area postrema (Van Houten and Posner,
1981; Nagano et al., 1995). Thus, it is suggested
that binding of insulin and IGF-1 to these area
postrema receptors mediates regulatory influ-
ences on cardiovascular and sympathetic ner-
vous dynamics (Kott et al., 1989).
In previous studies we have proposed that
both insulin and IGF-1 levels in circulation alter
cardiovascular dynamics by CNS-mediated me-
chanism (Hu et al., 1996; Wright-Richey et al.,
1994; Dunbar et al., 1996). Since the area pos-
trema is one of the significant communicating
areas between the brain and periphery, we
sought to investigate its role in this process.
In this study we evaluated the effects of pe-
ripherally administered insulin and IGF-1 on
cardiovascular dynamics and sympathetic nerve
activity in intact animals compared to animals
that had their area postrema removed.
MATERIALS AND METHODS
Normal male Wistar rats (Harlan Sprague
Dawley, Indianapolis, IN) weighing between
285-320 grams were utilized for all studies.
Prior to recording studies or following area
postrema removal the rats were housed with a
12:12-h light-dark cycle and an ambient tem-
perature of 23C. The animals were fed labo-
ratory rodent chow and given free access to
water. Blood samples were collected and body
weights determined. Rats were fasted prior to
any experimental recording procedure. Animal
studies were conducted in compliance with
applicable laws and regulations as well as
the principles expressed in the National Insti-
tutes of Health, USPHS, Guide for the Care
and Use of Laboratory Animals, and the stud-
ies were conducted on animals that were law-
fully acquired. The Wayne State University
Animal Care and Use Committee approved
use of animals.
Area postrema removal (APX) was conducted
using minor modification of the method of
Edwards and Ritter (1981). Briefly, rats were
anesthetized with ketamine and xylazine, 80/5
mg/kg (Bayer Corp., Shnunee Mission, KS),
placed in a Kopf stereotaxic apparatus, and a
dorsal midline incision was made through the
skin and epaxial musculature. With the aid of
a dissecting microscope, the atlanto-occipital
membrane was visualized and punctured, and
a portion of it was removed. The area postrema
was visualized on the dorsal surface of the
medulla at the caudal extent of the fourth ven-
tricle and removed by suction with a 26-gauge
needle attached to a vacuum line. With the
exception of the vacuum procedure, sham ope-
rations were identical to those described for
APX rats. The skin was closed and the animalsCARDIOVASCULAR AND SYMPATHETIC ACTIVITY 61
were maintained 3-4 weeks before they were
utilized. Following the study, histological sec-
tions were prepared to verify the APX.
Measurement of MAP and HR was conducted
on animals as described previously following
an 18-20 hour fast (Pete and Dunbar, 1998;
Duanmu et al., 1997). Briefly, the animals were
prepared for cardiovascular recording on a pad
heated to maintain the body temperature at
37 4-1C. The animals were anesthetized with a
mixture of urethane (0.5 g/kg) and c-chloralose
(80 mg/kg). The trachea was cannulated to min-
imize respiratory difficulties. Catheters made
of PE-50 tubing were filled with heparinized
saline (2,000 U/ml) and inserted into the femo-
ral artery to monitor arterial blood pressure via
aSpectra-Med pressure transducer (Spectra-Med,
Oxnard, CA) and into the femoral vein for
blood sampling and infusions.
The measurement of sympathetic nerve ac-
tivity was conducted as previously described
(Duanmu et al., 1997) with minor modifications.
To measure the sympathetic nerve activity the
lumbar sympathetic chain (L3- L5) was exposed
through a midline incision, dissected, cut, and
its rostral end placed on stainless steel electrodes
for recording of efferent nerve activity. Silicone
gel (Wacker Sil-Gel 601A and 601B mixture,
Iowa City, IA) was used to embed the nerve
bundle and electrodes and allowed to dry and
harden for 1 hour. Finally, the abdomen was
closed to prevent evaporation. The lumbar
sympathetic nerve activity (LSNA) was ampli-
fied (5,000-10,000 times) and filtered (low at
30 Hz, high at 1,000 Hz) using a Grass RPS 107
amplifier and a Grass IR Z probe (Grass
Instruments, Quincy, MA). The amplified and
filtered signal was channeled to an oscilloscope
HM205. An audio amplifier-loudspeaker (Grass
model AM8 audio monitor) was used for
auditory monitoring. Whole nerve activity was
obtained by rectifying and integrating the action
potentials in ls intervals using a data acquisition
system (Dasy Lab Data Acquisition System,
Phymed Scientific, Fishers, IN). At the end
of each experiment, hexamethonium chloride
(20mg/kg), a ganglionic blocker, was used to
determine the relative contribution of pre- and
postganglionic fibers to LSNA.
For the experimental recording period normal
and APX animals were infused with insulin
(5 U; Sigma Corp., St. Louis, MO) or IGF-1 (40 U;
Gerelech, Inc., San Francisco, CA) as a bolus and
the MAP, HR and LSNA recorded for 1 hour
as described above. In some studies to prevent
hypoglycemia glucose was infused first as a
bolus (45 mg) followed by a constant infusion
of 150mg/kg/hr starting at 15 min before insu-
lin. Blood samples were collected at specified
intervals for glucose and/or insulin determi-
nation. Glucose determinations were made us-
ing a glucose analyzer (YSI; Yellow Spring, OH)
and insulin was measured with a double anti-
body method using a kit (ICN Corp., Costa Mesa,
CA).
The data for MAP, HR and LSNA were
calculated for individual experiments as percent
change from basal (Time 0). The group data
were analyzed using ANOVA with repeated
measures and/or t-test where appropriate and
values expressed as means 4- SE.
RESULTS
The removal of the area postrema in normal rats
decreased the body weights initially at two
weeks but after 4-5 weeks the body weights
and plasma glucose levels were comparable to
normals (Tab. I). Also the basal plasma insulin,
basal MAP and HR were not different from
normals (Tab. I). When we infused insulin as a
bolus into normal rats there was a decrease in
MAP of approximately 20% after 20 minutes that
remained for 60minutes (Fig. 1A). It can also
be observed that bolus insulin infusion into
APX rats also resulted in a decrease in MAP
that reached a nadir after 20 minutes that
was slightly greater than that in normals, but
returned to basal levels above normals after 40TABLE Plasma glucose and insulin, and basal mean arterial pressure (MAP) and heart rate (HR) in normal rats and in rats
4-5 weeks after removal of the area postrema (APX)
Body wt. Glucose Insulin MAP HR
gm mg/dl uU/ml mm Hg beats/min
Cotrols 309 4-12 155 4- 78.5 36.0 4- 8.8 77.0 4- 4 365 4-14
(9) (9) (10) (10)
APX 295 4-18 158 4-10.1 37.0 4- 6.9 80.0 4- 6 358 4-13
(9) (9) (10) (10)
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FIGURE 1 The effect of systemic insulin infusion or saline onMAP (Panel A), HR (Panel B) and LSNA (Panel C) in normal and
APX rats. Insulin (5 U/animal) significantly decreased the MAP in normal (P < 0.001) and APX (P < 0.001) rats when compared
to saline controls. The HR was significantly increased in normals (P < 0.001) and APX (P < 0.001) rats. Insulin increased the
LSNA in normals (P < 0.001) and APX (P < 0.0001) rats compared to saline controls. Statistical comparison between groups made
byANOVA with repeated measures. *=significant (P < 0.05) differences between normal insulin and APX insulin versus normal
saline at selected time points. +=significant (P < 0.05) differences between normal and APX rats at selected time points. N=6, 5, 5
for saline controls, normal insulin and APX insulin, respectively.CARDIOVASCULAR AND SYMPATHETIC ACTIVITY 63
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FIGURE 2 The effect of systemic insulin (5 U/animal) infusion as a bolus with previous and subsequent variable glucose
infusion (100mg bolus plus -300mg/hr) to maintain euglycemia on MAP (Panel A), HR (Panel B) and LSNA (Panel C) in
normal and APX rats. Insulin significantly decreased the MAP (P < 0.001) and HR (P < 0.001) and increased the LSNA (P < 0.001)
in both normal and APX rats. Statistical comparisons between groups made byANOVA with repeated measures. *=significant
(P < 0.05) differences between normal and APX rats at selected time points. N=5 for both normals and APX animals.
minutes (Fig. 1A). The HR in response to insulin
increased approximately 10% in normal animals
but the increase in HR was significantly higher
(30%) in APX animals when compared to nor-
mals (Fig. 1B). The measurement of the lumbar
sympathetic nerve activity (LSNA) in these
animals demonstrated additionally that bolus in-
sulin infusion increased LSNA approximately
12% in normal animals. This response to insulin
was increased to significantly higher levels
(approximately 47%) in APX animals (Fig. 1C).
Insulin decreased the blood glucose in APX
animals to a greater extent when compared
to normals (Tab. II). When these same studies
were conducted with glucose infusion to pre-
vent hypoglycemia (plasma glucose maintained
above 70mg/dl), insulin decreased the MAP
to a slightly lower level in the APX animals64 R. FORD et al.
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FIGURE 3 The effect of systemic IGF-1 infusion onMAP (Panel A), HR (Panel B) and LSNA (Panel C) in normal and APX rats.
IGF-1 (40ug/animal) significantly decreased the MAP in normals (P <0.001) and APX (P < 0.0001) when compared to saline
controls. IGF-1 significantly (P < 0.01) increased the HR in APX animals compared to controls. IGF-1 significantly increased the
LSNA in normal (P <0.001) and APX (P <0.001) animals. Statistical comparisons between groups made by ANOVA with
repeated measures. *=significant (P < 0.05) differences between normaMGF-1 and APX-IGF-1 versus normal saline at selected
time points. +=significant (P < 0.05) differences between normaMGF-1 and APX-IGF-1 at selected time points. N=6, 6,5 for saline
controls, normal IGF-1 and APX IGF-1, respectively.
compared to normals (Fig. 2). When hypoglyce-
mia was prevented the HR was decreased in
normal and APX rats and the stimulation of
the LSNA was comparable between normal and
APX animals (Figs. 2B and C).
When we conducted these same studies using
IGF-1, we observed that IGF-1 infusion resulted
in an approximately 8% decreased MAP in
normal rats and IGF-1 infusion resulted in an
even greater decrease (20%) in APX rats (Fig.
3A). IGF-1 did not alter the heart rate in normal
but significantly increased it in the APX ani-
mals (Fig. 3B). IGF-1 infusion in both normal
and APX animals resulted in a significant in-
crease in LSNA activity that was comparable
between groups (Fig. 3C).CARDIOVASCULAR AND SYMPATHETIC ACTIVITY 65
TABLE II The effect of insulin and IGF-1 infusion on plasma glucose (mg/dl) in normal and APX rats
Time (minutes)
0 15 30 60
Insulin infusion
Normals
APX
Insulin infusion plus glucose
Normals
APX
IGF-1 infusion
Normals
APX
P< 0.05 vs. normals.
P < 0.05 vs. values at time 0.
107 +/- 4.5 65 +/- 13 34 +/- 16 33 +/- 15
(6) (6) (6) (6)
109 +/- 10 46 +/- 6.5 16 +/- 2.9
*,+ 25 +/- 3.4
(5) (5) (5) (5)
130 +/- 15 90 +/- 6 98 +/- 8 100 +/- 15
125 +/- 12 101 +/- 7 85 +/- 10 80 4-10
114 +/- 6 88 + 4 79 +/- 5 68 +/- 7
(5) (5) (5) (5)
100 +/- 5 97 +/- 15 82 +/- 12 101 +/- 14
(5) (5) (5) (5)
The plasma glucose levels were decreased to
a comparable degree in both normal and APX
rats in response to IGF-1 infusion (Tab. II).
DISCUSSION
In this study we have observed that insulin
administered peripherally resulted in a sus-
tained decrease in MAP in normals and in
animals that had their area postrema removed.
However, in APX animals insulin resulted
in a slightly greater decrease in MAP but result-
ed in a more rapid recovery. Our initial hypo-
thesis was that the insulin-induced decrease in
MAP was, in part, mediated by insulin entering
the CNS via area postrema transporters and
acting at CNS sites to augment the peripher-
ally mediated decreased MAP. However, the
above observations contrastingly support the
view that the insulin-mediated cardiovascular
responses that decrease MAP are the primary
result of direct vascular effects in the periphery
(Hausberg et al., 1995; Spraul et al., 1995). In
fact, following removal of the area postrema,
instead of the anticipated attenuation of the
insulin-mediated decrease in MAP, the initial
response to insulin was slightly greater, suggest-
ing that the area postrema was important in
facilitating not a dilatory but a pressor response.
Our observation would be consistent with previ-
ous studies that demonstrated that stimulation
of the area postrema acted to induce a pressor
response (Cai et al., 1996; Hegarty et al., 1995;
Suemori et al., 1994). However, this pressor
activity was not found in all studies (Gross
et al., 1990). In other investigations where the
area postrema was removed the animals tend-
ed to have lower basal MAP, again suggesting
a pressor role of area postrema (Skoog and
Mangiapane, 1988). In our study, however, the
initial insulin-induced decreased MAP had a
more rapid recovery to basal levels in the APX
animals. This more rapid recovery was also
associated with a greater increase in HR and
LSNA. Taken together this suggests that area
postrema removal decreased the basal constric-
tor tone but enhanced the sensitivity to activa-
tion of the sympathetic nervous outflow. Our
results also suggest that this increased sensitiv-
ity to sympathetic activation was likely due to
the greater hypoglycemia induced in response to
insulin noted in the APX animals. In these ani-
mals the blood glucose reached a significantly66 R. FORD et al.
lower nadir compared to normals that could
lead to greater activation of sympathetic coun-
ter regulatory outflow (Bonigut et al., 1997;
Skoog and Mangiapane, 1988). Although our
animals had similar fasting plasma glucose
levels, the tendency for lower blood glucose
and impaired glucose regulation is consistent
with previous observations of decreased caloric
regulation (Contreras et al., 1982). Indeed, it has
been demonstrated that the counter regulatory
responses to changes in plasma nutrients are
altered APX animals (Curtis et al., 1996).
Systemic IGF-1 infusion also resulted in a
greater decrease in MAP in APX rats when
compared to normals. The IGF-1 response sup-
ports our previous study which suggests that
IGF-1 actions on cardiovascular dynamics are
mainly peripheral (Duanmu et al., 1997). The ob-
servation that the decreased MAP was greater
following IGF-1 with the HR and LSNA re-
sponses comparable to normals may be due to
the difference in the degree of hypoglycemia
that IGF-1 induced. Systemically administered
IGF-1 decreased blood glucose to a lesser degree
when compared to systemic insulin in both nor-
mal and APX animals. Thus, in the absence of
the more pronounced hypoglycemia observed
in the insulin studies, the enhanced increase
in HR and LSNA noted following insulin was
not observed.
Nevertheless, this study does not reconcile
the observations that insulin and IGF-1 admin-
istered into the central nervous system can al-
ter cardiovascular dynamics (Hu et al., 1996;
Schultz-Klarr et al., 1994). It may be that the re-
lationship between the insulin and IGF-1 bind-
ing sites in the area postrema may result in their
translocation to CNS sites at the level of the
brainstem, specifically the NTS. These sites may
be involved in other physiological regulations
such as gastrointestinal function (Carpenter
and Briggs, 1986) while the regulation of cardio-
vascular responses may be mediated at other
CNS sites of blood-brain communication such
as sites more proximal to the hypothalamus
(Ferguson and Bains, 1996).
Thus, even though insulin and IGF-1 bind to
receptors in the area postrema and can be
demonstrated to translocate to the CNS, we
suggest that this process in the area postrema
does not appear to be involved in the insulin- or
IGF-mediated decreased MAP and increased
vascular flow. This study supports a conclusion
that insulin and IGF-1 mainly exert their action
peripherally to enhance blood flow and decrease
MAP.
Acknowledgement
Supported by NIH GM-08167; NIH MH-47181.
Re[erences
Adachi, A., Kobashi, M., Miyoshi, N. and Tsukamoto, G.
(1991) Chemosensitive neurons in the area postrema of
the rat and their possible functions, Brain Res. Bull., 26,
137-140.
Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A.
and Mark, A. L. (1991) Hyperinsulinemia produces both
sympathetic neural activation and vasodilation in normal
humans, J. Clin. Invest., 87, 2246-2252.
Bernstein, I. L. (1996) Neural mediation of food aversions and
anorexia induced by tumor necrosis factors and tumors,
Neurosci. Behav. Rev., 20, 177-181.
Bonigut, S., Bonham, A. C. and Stebbins, C. L. (1997) Area
postrema-induced inhibition of the exercise pressor re-
flexes, Am. J. Physiol., 272, H1650-H1655.
Cai, Y., Hay, M. and Bishop, V. S. (1996) Synaptic connec-
tions and interaction between area postrema and the
nucleus tractus solitarius, Brain Res., 724, 121-124.
Calingasan, N. Y. and Ritter, S. (1992) Hypothalamic
paraventricular nucleus lesion do not abolish glucoprivic
and lipoprivic feeding, Brain Res., 395, 25-31.
Carpenter, D. O. and Briggs, D. B. (1986) Insulin excites
neurons of the area postrema and causes emesis, Neurosci.
Lett., 68, 85-89.
Contreras, R. J., Fox, E. and Drugovich, M. L. (1982) Area
postrema lesions produce feeding deficits in the rat: effects
of preoperative dieting and 2-deoxy-D-glucose, Physiol.
Behav., 29, 875-884.
Cox, B. F. and Bishop, V. S. (1991) Neural and humoral
mechanisms of angiotensin-dependent hypertension, Am.
J. Physiol., 261, H1284-H1291.
Curtis, K. S., Verbalis, J. S. and Stricker, E. M. (1996) Area
postrema lesions in rats appear to disrupt rapid feedback
inhibition of fluid intake, Brain Res., 726, 31- 38.
Duanmu, Z., Lapanowski, K. and Dunbar, J. C. (1997) Insulin
link growth factor-1 decreases sympathetic nerve activity.
The effect is modulated by glycemic status, Proc. Soc. Exp.
Biol. Med., 216, 93-97.
Dunbar, J. C., O’Leary, D. S., Wang, G. and Richey, J. (1996)
Mechanisms mediating the insulin-induced hypotension
in rats: A role for nitric oxide and autonomic mediators,
Acta Diabetol., 33, 263-268.CARDIOVASCULAR AND SYMPATHETIC ACTIVITY 67
Edwards, G. L. and Ritter, R. C. (1981) Ablation of the area
postrema causes exaggerated consumption of preferred
food in the rat, Brain Res., 216, 265-276.
Ferguson, A. V. and Bains, J. S. (1996) Electrophysiology of
the circumventricular organs, Front. Neuroendocrinol., 17,
440-475.
Gross, P. M., Wainman, D. S., Shover, S. W., Wall, K. M. and
Ferguson, A. V. (1990) Metabolic activation of efferent
pathways from the rat area postrema, Am. J. Physiol., 258,
R788- R797.
Hausberg, M., Mark, A. L., Hoffman, R. P., Sinkey, C. A. and
Anderson, E. A. (1995) Dissociation of sympathoexcitatory
and vasodilatory actions of modesty elevated plasma
insulin levels, J. Hypertens., 13, 1015-1021.
Hegarty, A. A., Hayward, L. F. and Felder, R. B. (1995)
Sympathetic response to stimulation of area postrema in
decerebrate and anesthetized rats, Am. J. Physiol., 268,
H1086-H1095.
Hu, Y., Pete, G., Walsh, M. F. and Dunbar, J. C. (1996) Central
IGF-1 decreases systemic blood pressure and increases
blood flow in selective vascular beds, Horm. Metab. Res., 28,
211-214.
Kenney, N. J., Tomoyasu, N. and Burkhart, M. K. (1994) Food
aversion induced by area postrema ablation, Appetite, 22,
205- 220.
Kott, J. N., Kenney, N. J., Bhatia, A. J. and Bhatia, A. M. (1989)
Response to chronic insulin administration: effect of area
postrema ablation, Physiol. Behav., 46, 971- 976.
Nagano, T., Sato, M., Mori, Y., Du, Y., Takagi, H. and
Tohyama, M. (1995) Regional distribution of messenger
RNA encoding the insulin-like growth factor Type 2
receptor in the rat lower brain stem, Brain Res. Mol. Brain
Res., 32, 14- 24.
Nakayama, Y., Takano, Y., Eguchi, K., Migita, K., Saito, R.,
Tsujimoto, G. and Kamiya, H. (1997) Modulation of the
arterial baroreceptor reflex by the vasopressin receptor in
the area postrema of the hypertensive rats, Neurosci. Lett.,
226, 179 182.
Pete, G. and Dunbar, J. C. (1998) Regional blood flow
dynamics in response to insulin and IGF-1 in diabetic
animals, Clin. Exp. Hypertens., 20, 67-83.
Pete, G., Hu, Y., Walsh, M. F., Sowers, J. and Dunbar, J. C.
(1996) IGF-1 decreases mean blood pressure and selec-
tively increases regional blood flow in normal rats, Proc.
Soc. Biol. Med., 213, 187-192.
Schultz-Klarr, S., Wright-Richey, J. and Dunbar, J. C. (1994)
The effect of systemic versus intracerebroventricular ad-
ministration of insulin, 2-deoxyglucose and glucose
on metabolic and cardiovascular responses, JAAMP, 5,
152-158.
Skoog, K. M. and Mangiapane, M. L. (1988) Area postrema
and cardiovascular regulation in rats, Am. J. Physiol., 254,
H963-H969.
Spraul, M., Rauussin, E. and Baron, A. D. (1995) Lack of
relationship between muscle sympathetic nerve activity
and skeletal muscle vasodilation in response to insulin
infusion, Diabetologia, 39, 91-96.
Suemori, K., Kobashi, M. and Adachi, A. (1994) Effect of
gastric distension and electrical stimulation of dorsal
medial medulla on neurons in parabrachial nucleus of
rats, J. Auton. Nerv. Sys., 48, 221- 229.
Van Houten, M. and Posner, B. I. (1981) Specific binding and
internalization of blood-borne [125 I]-iodoinsulin by neu-
rons of the rat area postrema, Endocrinology, 109, 853-859.
Wade, G. N., Schneider, J. E. and Li, H. Y. (1996) Control of
fertility by metabolic cues, Am. J. Physiol., 270, El-E19.
Wright-Richey, J., Schultz-Klarr, S. and Dunbar, J. C. (1994)
The effect of ventral medial hypothalamic lesion on the
insulin-induced hypotensive response in normal rats, Acta
Diabetol., 31, 91 97.